GILENYA vs MAYZENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. GILENYA and MAYZENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GILENYA	MAYZENT
Rating	70/100	70/100
Pharmacy pays	~$126.02 /30	—
Type	RX	RX
Active ingredient	FINGOLIMOD HYDROCHLORIDE	SIPONIMOD
Manufacturer	Novartis	Novartis
Dosage forms	Capsule	Tablet
Drug class	Sphingosine 1-Phosphate Receptor Modulator	—
Boxed warning	None	None
Half-life	about 6 to 9 days (average apparent terminal half-life)	—
Treats	Relapsing-Remitting Multiple Sclerosis	Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

gilenya mayzent

Rating

70/100

Pharmacy pays

~$126.02 /30

—

Type

Active ingredient

FINGOLIMOD HYDROCHLORIDE

SIPONIMOD

Manufacturer

Novartis

Dosage forms

Capsule

Tablet

Drug class

Sphingosine 1-Phosphate Receptor Modulator

—

Boxed warning

None

Half-life

about 6 to 9 days (average apparent terminal half-life)

—

Treats

Relapsing-Remitting Multiple Sclerosis

Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

Which is better-rated, Gilenya or Mayzent?

Gilenya and Mayzent are tied at 3.5 out of 5 by our independent rating.

What is the difference between Gilenya and Mayzent?

Gilenya contains Fingolimod Hydrochloride, while Mayzent contains Siponimod — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.